Completed PHASE1 INTERVENTIONAL 1-arm NCT02156557

Study of KCC Peptide Application in the Colon (KCC 1B)

Phase 1B Study of KCC Peptide Application in the Colon

Sponsor: Danielle Kim Turgeon

Conditions Colon Polyps Colorectal Cancer Inflammatory Bowel Disease (IBD)

Updated 6 times since 2017 Last updated: Apr 1, 2017 Started: Jun 30, 2014 Primary completion: Jul 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Colon Polyps and Colorectal Cancer, this trial is completed. The trial is conducted by Danielle Kim Turgeon and has accumulated 6 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danielle Kim Turgeon
Olympus Corporation

Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ann Arbor, United States